loadpatents
Patent applications and USPTO patent grants for Wertz; Ingrid.The latest application filed is for "combination therapy with an anti-her2 antibody-drug conjugate and a bcl-2 inhibitor".
Patent | Date |
---|---|
Combination Therapy With An Anti-her2 Antibody-drug Conjugate And A Bcl-2 Inhibitor App 20210213130 - Phillips; Gail Lewis ;   et al. | 2021-07-15 |
Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor Grant 10,898,570 - Phillips , et al. January 26, 2 | 2021-01-26 |
Piperidine derivatives as inhibitors of ubiquitin specific protease 7 Grant 10,766,903 - O'Dowd , et al. Sep | 2020-09-08 |
Piperidine Derivatives As Inhibitors Of Ubiquitin Specific Protease 7 App 20190256518 - O'DOWD; Colin ;   et al. | 2019-08-22 |
Protac Antibody Conjugates And Methods Of Use App 20190175612 - Pillow; Thomas ;   et al. | 2019-06-13 |
Combination Therapy With An Anti-her2 Antibody-drug Conjugate And A Bcl-2 Inhibitor App 20180140700 - Phillips; Gail Lewis ;   et al. | 2018-05-24 |
Methods Of Treatment With Taselisib App 20160375033 - Edgar; Kyle ;   et al. | 2016-12-29 |
Biomarkers For Treatment With Anti-tubulin Chemotherapeutic Compounds App 20160136295 - Wertz; Ingrid | 2016-05-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.